Updated recommendation by the nomination committee of Navamedic ASA
Following Navamedic ASA’s acquisition of Sensidose AB, the nomination committee recommends that Åsa Kornfeld, previous Board member in Sensidose AB, is elected as a new Navamedic ASA Board member in addition to Terje Bakken (Chairman), Narve Reiten, Jostein Davidsen, Annika Kollén and Edmée Steenken on the Annual General Meeting on June 1st, 2023. Åsa Kornfeld served as a Board member of Sensidose AB when Navamedic ASA acquired the company. She is Pricing & Access Lead in Recordati Rare Diseases based in Paris, and has extensive experience from the pharmaceutical industry, with more